Assessing treatment outcomes for benign prostate hyperplasia in Hong Kong
A Prospective Assessment of the Perioperative Parameter and Treatment Outcomes of Surgical Treatment for Benign Prostate Hyperplasia in Hong Kong
This study is trying to see how well different surgical treatments for benign prostate hyperplasia work for men in Hong Kong who have not found relief from their urinary symptoms with medication.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 2000 (estimated) |
| Ages | 18 Years and up |
| Sex | Male |
| Sponsor | Chinese University of Hong Kong Academic / other |
| Locations | 3 sites (Hong Kong and 2 other locations) |
| Trial ID | NCT05292235 on ClinicalTrials.gov |
What this trial studies
This observational study aims to create a prospective data registry to evaluate the treatment outcomes and complications associated with various surgical approaches for benign prostatic hyperplasia (BPH) in Hong Kong. It focuses on patients experiencing lower urinary tract symptoms that are unresponsive to medication or those suffering from complications related to BPH. The study will analyze different surgical interventions, including traditional and minimally invasive techniques, to determine their effectiveness and potential adverse effects. By gathering comprehensive data, the study seeks to fill the gap in large-scale research on surgical treatments for BPH.
Who should consider this trial
Good fit: Ideal candidates for this study are men aged 18 and older who are experiencing significant symptoms or complications from benign prostatic hyperplasia.
Not a fit: Patients who are unable to provide consent will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the most effective surgical treatments for benign prostatic hyperplasia, improving patient outcomes.
How similar studies have performed: While there is a lack of large-scale studies on the surgical treatment of BPH, this registry aims to address that gap and could provide novel insights into treatment outcomes.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient at the age of 18 or above Exclusion Criteria: * Patient is unable to give consent
Where this trial is running
Hong Kong and 2 other locations
- Alice Ho Miu Ling Nethersole Hospital — Hong Kong, Hong Kong (Recruiting)
- North District Hospital — Hong Kong, Hong Kong (Recruiting)
- Prince of Wales Hospital — Shatin, Hong Kong (Recruiting)
Study contacts
- Principal investigator: Chi Fai NG, MD — Chinese University of Hong Kong
- Study coordinator: Chi Fai NG, MD
- Email: ngcf@surgeryh.cuhk.edu.hk
- Phone: 35052625
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.